Unknown Status PHASE3 Interventional NCT00632983
Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer
Acitve Monitoring, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer
Sponsor: Oxford University Hospitals NHS Trust
Conditions
Anxiety Disorder Long-term Effects Secondary to Cancer Therapy in Adults Prostate Cancer Sexual Dysfunction Urinary Complications
Interventions
3-dimensional conformal radiation therapy active surveillance assessment of therapy complications cyproterone acetate medical chart review quality-of-life assessment questionnaire administration releasing hormone agonist therapy therapeutic conventional surgery therapeutic lymphadenectomy
Updated 1 time since 2017 Last updated: Mar 8, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Anxiety Disorder and Long-term Effects Secondary to Cancer Therapy in Adults, this trial is ongoing. The trial is conducted by Oxford University Hospitals NHS Trust and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Unknown Status — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Oxford University Hospitals NHS Trust
Data source: National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .